Helmsley Electrophysiology Center, Mount Sinai Hospital, New York, New York, USA. Electronic address: https://twitter.com/joshuamlampertmd.
Mount Sinai Heart, Mount Sinai Hospital, New York, New York, USA.
JACC Clin Electrophysiol. 2023 Aug;9(8 Pt 3):1804-1815. doi: 10.1016/j.jacep.2023.04.006. Epub 2023 Jun 21.
Interatrial block (IAB) is associated with thromboembolism and atrial arrhythmias. However, prior studies included small patient cohorts so it remains unclear whether IAB predicts adverse outcomes particularly in context of atrial fibrillation (AF)/atrial flutter (AFL).
This study sought to determine whether IAB portends increased stroke risk in a large cohort in the presence or absence of AFAF/AFL.
We performed a 5-center retrospective analysis of 4,837,989 electrocardiograms (ECGs) from 1,228,291 patients. IAB was defined as P-wave duration ≥120 ms in leads II, III, or aVF. Measurements were extracted as .XML files. After excluding patients with prior AF/AFL, 1,825,958 ECGs from 458,994 patients remained. Outcomes were analyzed using restricted mean survival time analysis and restricted mean time lost.
There were 86,317 patients with IAB and 355,032 patients without IAB. IAB prevalence in the cohort was 19.6% and was most common in Black (26.1%), White (20.9%), and Hispanic (18.5%) patients and least prevalent in Native Americans (9.2%). IAB was independently associated with increased stroke probability (restricted mean time lost ratio coefficient [RMTLRC]: 1.43; 95% CI: 1.35-1.51; tau = 1,895), mortality (RMTLRC: 1.14; 95% CI: 1.07-1.21; tau = 1,924), heart failure (RMTLRC: 1.94; 95% CI: 1.83-2.04; tau = 1,921), systemic thromboembolism (RMTLRC: 1.62; 95% CI: 1.53-1.71; tau = 1,897), and incident AF/AFL (RMTLRC: 1.16; 95% CI: 1.10-1.22; tau = 1,888). IAB was not associated with stroke in patients with pre-existing AF/AFL.
IAB is independently associated with stroke in patients with no history of AF/AFL even after adjustment for incident AF/AFL and CHADS-VASc score. Patients are at increased risk of stroke even when AF/AFL is not identified.
房间隔阻滞(IAB)与血栓栓塞和房性心律失常有关。然而,先前的研究纳入的患者队列较小,因此仍然不清楚 IAB 是否预测不良结局,尤其是在存在房颤/房扑(AF/AFL)的情况下。
本研究旨在确定在存在或不存在 AF/AFL 的情况下,IAB 是否预示着大队列中的卒中风险增加。
我们对来自 1228291 名患者的 4837989 份心电图(ECG)进行了 5 个中心的回顾性分析。IAB 定义为 II、III 或 aVF 导联的 P 波持续时间≥120ms。测量值以.XML 文件形式提取。在排除有既往 AF/AFL 的患者后,458994 名患者中有 1825958 份 ECG 仍然存在。使用受限平均生存时间分析和受限平均时间损失来分析结果。
共有 86317 名患者有 IAB,355032 名患者没有 IAB。该队列中 IAB 的患病率为 19.6%,在黑种人(26.1%)、白种人(20.9%)和西班牙裔(18.5%)患者中最为常见,在美洲原住民中最为少见(9.2%)。IAB 与卒中概率增加独立相关(受限平均时间损失比系数[RMTLRC]:1.43;95%CI:1.35-1.51;tau=1895)、死亡率(RMTLRC:1.14;95%CI:1.07-1.21;tau=1924)、心力衰竭(RMTLRC:1.94;95%CI:1.83-2.04;tau=1921)、系统性血栓栓塞(RMTLRC:1.62;95%CI:1.53-1.71;tau=1897)和新发 AF/AFL(RMTLRC:1.16;95%CI:1.10-1.22;tau=1888)。在有既往 AF/AFL 的患者中,IAB 与卒中无关。
即使在调整新发 AF/AFL 和 CHADS-VASc 评分后,IAB 与无 AF/AFL 病史患者的卒中也独立相关。即使 AF/AFL 未被识别,患者也处于更高的卒中风险中。